Sasahara Yosuke, Akata Kentaro, Yamasaki Kei, Orihashi Takeshi, Yatera Kazuhiro
Department of Pulmonary Medicine Kitakyushu General Hospital Kitakyushu Japan.
Division of Infection Control and Prevention University of Occupational and Environmental Health, Japan Kitakyushu Japan.
Respirol Case Rep. 2024 Jul 3;12(7):e01423. doi: 10.1002/rcr2.1423. eCollection 2024 Jul.
Allergic bronchopulmonary aspergillosis (ABPA) is an inflammatory disease induced by exaggerated immune responses to species. Although ABPA has a high recurrence (48%), its instances with sequential isolation of distinct species are sporadic. Only one case report has documented the metachronous isolation of and . However, no reported cases of metachronous isolation involving three distinct species exist. Herein, we report a novel case of a 47-year-old Japanese man with sequential metachronous isolation of , , and . Initially presenting with symptoms of productive cough and pulmonary infiltration, the patient experienced two relapses following treatment with oral prednisolone. Adjustments in therapy, including voriconazole and a tailored corticosteroid regimen, resulted in significant improvement without relapse for over 6 months. This case report highlights the challenges and successful management of ABPA involving multiple species.
变应性支气管肺曲霉病(ABPA)是一种由对特定物种的过度免疫反应引起的炎症性疾病。尽管ABPA复发率很高(48%),但其先后分离出不同特定物种的病例较为散在。仅有一份病例报告记录了先后分离出两种特定物种的情况。然而,尚无涉及三种不同特定物种先后分离的病例报告。在此,我们报告一例新病例,一名47岁日本男性先后分离出三种不同的特定物种。该患者最初表现为咳痰和肺部浸润症状,口服泼尼松龙治疗后经历了两次复发。调整治疗方案,包括使用伏立康唑和量身定制的皮质类固醇方案,病情显著改善,6个多月未复发。本病例报告突出了涉及多种特定物种的ABPA的挑战及成功管理。